MOUNTAIN VIEW, Calif.,
November 20, 2002 – IMPAC Medical Systems, Inc. (Nasdaq:
IMPC) announced today the initial public offering of 2,187,500
shares of its common stock at $15.00 per share. Of the total,
312,500 shares were offered by selling stockholders. The company's
common stock will be listed on the Nasdaq National Market under
the symbol “IMPC”.
Thomas Weisel Partners LLC acted as lead manager and SG Cowen
Securities Corporation and U.S. Bancorp Piper Jaffray acted as
co-managers of the underwriting group. The underwriters have a
30-day option to purchase up to 328,125 additional shares of
common stock from certain stockholders solely to cover
over-allotments, if any.
IMPAC Medical Systems, Inc. is a leading provider of information
technology systems for cancer care. IMPAC’s products provide an
integrated clinical and administrative solution to manage the
complexities of cancer care, from detection and diagnosis through
treatment and follow-up. Specializing in the development of
practice management, electronic medical record, image management
and decision support software, IMPAC offers practical solutions
that help healthcare providers better manage the process of
delivering care.
Copies of the prospectus may be obtained from: Thomas Weisel
Partners LLC, One Montgomery Street, San Francisco, CA 94104. |
|
Michelle Arnold
Public Relations Manager
IMPAC Medical Systems, Inc.
650-623-8883
pr@impac.com
http://www.impac.com
Link Disclaimer
|
